Systematic reviews document modest yet consistent reductions in body weight, waist circumference, and visceral adipose tissue among overweight and obese individuals following probiotic administration, with Lactobacillus species representing the most extensively investigated strains (419422)
But what most buyers do not know is exactly what they are getting, how it differs from pharmaceutical-grade semaglutide, and why the quality gap matters more than most people realize
A., Karadsheh, S
PMID: 18061177
Romero-Gmez M, Lawitz E, Shankar RR, Chaudhri E, Liu J, Lam RLH, Kaufman KD, Engel SS, Group (2023) A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with nonalcoholic fatty liver disease
Until recently, the published studies with the new obesity pharmacotherapies have had up to 2 years follow-up [12]